Incyte Corporation is a Delaware-based drug discovery and development company with a growing pipeline of oral compounds to treat HIV, inflammation, cancer and diabetes. Incyte has created an agile, highly focused and efficient research organization that has launched and fully staffed three internal discovery programs. The company trades on NASDAQ under the symbol INCY. It is headquartered in Wilmington, Del.

Website: incyte.com

Phone: (302) 498-6700